PunchYour best still to come, Ronaldo tells injured KvaratskheliaThe Jerusalem PostMDA inaugurates 96 new ambulances marking 96 years of lifesaving workESPN Deportes¿Qué equipos pueden clasificar en la jornada doble?ESPNIt's almost time for college hoops! Jay Bilas picks his top players to watchBollywood HungamaViraj Ghelani and Arjun Tanwar starrer Party Animals trailer out ahead of November 20 releaseRTP DesportoAntónio Salvador aponta o dedo ao plantel do Sp. BragaDaily MaverickGROUNDUP: Tshwane’s drinking water crisis a wake-up call for SA as sewage pollution sickens hundreds
KioskNews
The Daily Newsstand · Free, Always
Wednesday, October 21, 2026
Language
Seeking Alpha·United States·

Voyager Therapeutics names Robin Swartz as successor to CEO Alfred Sandrock

Translate

Preeti Singh

  • Voyager Therapeutics (VYGR) appointed Robin Swartz, its current chief business officer and chief operating officer, as president effective October 20, 2026.
  • Swartz is expected to succeed Alfred Sandrock Jr. as CEO in the first quarter of 2027, following initial acute safety data from a clinical trial of the company’s investigational tau-silencing gene therapy VY1706 in adults with early Alzheimer’s disease.
  • Sandrock will remain on the board to provide strategic guidance.

Recommended For You

Create Your Free Account to Keep Reading

Get the confidence to navigate an uncertain market with free breaking news and stock alerts.

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.